Loading clinical trials...

COMPLETEDPHASE3

Osteopathy and Obstructive Sleep Apnea Syndrome II

A Single Blind Cross Over Trial to Compare Osteopathic Compression of Pterygopalatine Node to Sham in Patients With Obstructive Sleep Apnea Syndrome and in Healthy Subjects

NCT01822743•Assistance Publique - Hôpitaux de Paris

View on ClinicalTrials.gov

Summary

The main objective is to evaluate an osteopathic compression of pterygopalatine node in healthy subjects and patients suffering from obstructive apnea syndrome (OSA).

Detailed Description

Osteopathic compression will be compared to a sham manoeuvre in a cross over design on apnea hypopnea index, pharyngeal collapsibility and symptoms in patients suffering from OSA, and on symptoms and pharyngeal collapsibility in healthy subjects.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Obstructive sleep apnea syndrome patient:
•Male or Female aged 18 years or more
•Obstructive sleep apnea syndrome with apnea/hypopnea index \> or = 15/hour
•Body mass Index \<40kg/m2
•Male or Female aged ≥18 and ≤ 40 years
•No obstructive sleep apnea syndrome
•Body mass Index \<30kg/m2
•No chronicle respiratory, neurological, cardiac or able to deteriorate sleep quality disease
•Low obstructive sleep apnea syndrome probability measured with Berlin Scale

Exclusion Criteria

•Pregnant or lactating women
•Participating to another trial
•Acute infectious disease of upper respiratory airway tract at inclusion
•Complete nasal obstruction
•Facial neuralgia at inclusion
•Patients not able to stop treatment for OSA within one week before each visit
•Allergy to latex
•Dental extraction within 15 days before inclusion
•Pharyngeal surgery in the past
•Incapable adult
+12 more criteria

Locations (1)

Service des pathologies du sommeil, Pitié-Salpêtrière hospital

Paris, France

Key Dates

Start Date

January 1, 2012

Primary Completion Date

March 1, 2014

Completion Date

March 1, 2014

Last Updated

January 25, 2022

Enrollment

ACTUAL participants

Conditions

Obstructive Sleep Apnea Syndrome

Interventions

Osteopathic manipulative treatment

PROCEDURE

sham comparator

PROCEDURE

Fascial Mobilization Along the Vagus Nerve and Its Effects on Acute Physiological Parameters in Obstructive Sleep Apnea

NCT07169058

Obstructive Sleep Apnea Syndromes

View study

COMPLETEDNA

Study of Acceptability and Tolerance of an Orofacial Myofunctional Rehabilitation Pacifier in Infants

NCT06489223

Obstructive Sleep Apnea Syndrome

View study

WITHDRAWNNA

Didgeridoo Treatment to Improve Pharyngeal Compliance in Obstructive Sleep Apnea-hypopnea Syndrome in Children

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 25, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Osteopathy and Obstructive Sleep Apnea Syndrome II

Inclusion Criteria

Exclusion Criteria

Fascial Mobilization Along the Vagus Nerve and Its Effects on Acute Physiological Parameters in Obstructive Sleep Apnea

Study of Acceptability and Tolerance of an Orofacial Myofunctional Rehabilitation Pacifier in Infants

Didgeridoo Treatment to Improve Pharyngeal Compliance in Obstructive Sleep Apnea-hypopnea Syndrome in Children

PROMAD: Predicting Therapeutic Outcome of Mandibular Advancement Device Treatment in Obstructive Sleep Apnea

Obstructive Sleep Apnea Syndrome: Evaluation of the Efficacy of Sleepinnov© (Spiri+) Continuous Positive Airway Pressure Device

Internal and Predictive Validity of Epworth Sleepiness Scale to Evaluate Vigilance of Patient Treated for Obstructive Sleep Apnea Syndrome.